Get the Stockscreener App
25.55
2.36%
0.59
After Hours:
25.55
Upstream Bio Inc stock is traded at $25.55, with a volume of 384.48K.
It is up +2.36% in the last 24 hours and up +14.42% over the past month.
Upstream Bio Inc is a clinical-stage biotechnology company developing treatments for inflammatory diseases, with an initial focus on severe respiratory disorders. It is developing verekitug, the known antagonist currently in clinical development that targets the receptor for Thymic Stromal Lymphopoietin (TSLP), a cytokine that is a clinically validated driver of inflammatory response positioned upstream of multiple signaling cascades that affect a variety of immune-mediated diseases.
See More
Previous Close:
$24.96
Open:
$24.71
24h Volume:
384.48K
Relative Volume:
0.86
Market Cap:
$1.38B
Revenue:
$2.22M
Net Income/Loss:
$-40.51M
P/E Ratio:
-19.89
EPS:
-1.2847
Net Cash Flow:
$-46.53M
1W Performance:
+4.16%
1M Performance:
+14.42%
6M Performance:
+186.11%
1Y Performance:
+43.54%
1-Day Range:
$24.12
$26.10
1-Week Range:
$24.10
$26.20
52-Week Range:
$5.14
$26.90
Upstream Bio Inc Stock (UPB) Company Profile
Name
Upstream Bio Inc
Sector
Industry
Phone
781-208-2466
Address
890 WINTER STREET, SUITE 200, WALTHAM
Compare UPB with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
UPB
Upstream Bio Inc
|
25.55 | 1.35B | 2.22M | -40.51M | -46.53M | -1.2847 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.76 | 107.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
755.90 | 77.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
436.38 | 58.90B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
918.92 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
198.76 | 42.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Upstream Bio Inc Stock (UPB) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-18-25 | Initiated | Evercore ISI | Outperform |
| Oct-14-25 | Initiated | Truist | Buy |
| Nov-05-24 | Initiated | JP Morgan | Overweight |
| Nov-05-24 | Initiated | Piper Sandler | Overweight |
| Nov-05-24 | Initiated | TD Cowen | Buy |
| Nov-05-24 | Initiated | William Blair | Outperform |
View All
Upstream Bio Inc Stock (UPB) Latest News
Commit To Buy Upstream Bio At $20, Earn 80.2% Annualized Using Options - Nasdaq
Why Upstream Bio Inc. stock is popular among millennialsEarnings Trend Report & Free Low Drawdown Momentum Trade Ideas - newser.com
How strong is Upstream Bio Inc. stock revenue growthEarnings Miss & Stock Portfolio Risk Management - newser.com
What risks investors should watch in Upstream Bio Inc. stock2025 Volatility Report & Growth-Oriented Investment Plans - newser.com
Using data filters to optimize entry into Upstream Bio Inc.Earnings Recap Summary & Daily Stock Momentum Reports - newser.com
Top investors say Upstream Bio Inc (UPB) ticks everything they need - Setenews
Upstream Bio (NASDAQ:UPB) Now Covered by Evercore ISI - Defense World
Upstream Bioprocessing Market on Track for Strong Growth, Estimated to Grow at 12.4% CAGR Through 2029 - openPR.com
Analyzing Upstream Bio Inc. with multi timeframe chartsTrade Entry Report & Risk Adjusted Swing Trade Ideas - newser.com
Upstream Bio, Inc.Common Stock (NQ: UPB - FinancialContent
Evercore ISI Group Initiates Coverage of Upstream Bio (UPB) with Outperform Recommendation - Nasdaq
Upstream Bio initiated with an Outperform at Evercore ISI - MSN
Upstream Bio, Inc.’s Verekitug: A Promising Buy with Blockbuster Potential in Asthma and COPD Markets - TipRanks
Why hedge funds are buying Upstream Bio Inc. stockTrade Analysis Summary & Verified Entry Point Detection - newser.com
What earnings revisions data tells us about Upstream Bio Inc.2025 Price Momentum & Community Driven Trade Alerts - newser.com
Ranking Upstream Bio Inc. among high performing stocks via toolsJuly 2025 Rallies & Daily Price Action Insights - newser.com
Can momentum traders help lift Upstream Bio Inc.Earnings Risk Summary & Smart Investment Allocation Insights - newser.com
Is Upstream Bio Inc. stock trading at a premium valuationEarnings Risk Summary & Smart Swing Trading Alerts - newser.com
Can Upstream Bio Inc. stock resist sector downturnsShort Setup & Real-Time Volume Triggers - newser.com
Candlestick signals on Upstream Bio Inc. stock todayPortfolio Gains Summary & Fast Exit Strategy with Risk Control - newser.com
Is Upstream Bio Inc. stock dividend yield sustainable2025 Breakouts & Breakdowns & AI Forecast for Swing Trade Picks - newser.com
Upstream Bio Reports Progress in Respiratory Trials - MSN
Custom watchlist performance reports with Upstream Bio Inc.July 2025 Fed Impact & Real-Time Market Trend Scan - newser.com
What dividend safety score for Upstream Bio Inc. stockIndex Update & Reliable Price Breakout Alerts - newser.com
Upstream Bio Inc Stock Analysis and ForecastBearish Engulfing Patterns & Achieve Consistent Profits - earlytimes.in
Can Upstream Bio Inc. stock sustain revenue growthQuarterly Portfolio Report & Long-Term Capital Growth Strategies - newser.com
Will Upstream Bio Inc. stock outperform growth indexesJuly 2025 Momentum & Weekly Breakout Stock Alerts - newser.com
3 Best Biotech Stocks to Buy Now, 11/12/2025, According to Top Analysts - TipRanks
Can Upstream Bio Inc. stock deliver surprise earnings beatTrade Volume Report & Risk Controlled Stock Pick Alerts - newser.com
Why Upstream Bio Inc. stock remains undervaluedMarket Performance Recap & Growth Focused Stock Pick Reports - newser.com
Published on: 2025-11-08 03:19:27 - newser.com
Q3 EPS Estimates for Upstream Bio Lifted by William Blair - Defense World
Upstream Bio Inc Files for Mixed Shelf ; Size Not DisclosedSEC Filing - 富途牛牛
How resilient is Upstream Bio Inc. stock in market downturnsJuly 2025 Update & Safe Capital Allocation Plans - newser.com
Will Upstream Bio Inc. stock recover faster than peersJuly 2025 Movers & Weekly High Return Forecasts - Fundação Cultural do Pará
Upstream Bio Inc Stock (UPB) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.38%
1.42%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):